StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ADRX

ADARx Pharmaceuticals, Inc.

ADRX Nasdaq Pharmaceutical Preparations EDGAR ↗
$12.79
-1.37 -9.68%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$1.42B
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
-$94.4M
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
$571M
Total assets ⓘ
$929M
Gross margin ⓘ
—
52-week range ⓘ
$12.50 – $23.21